The IMID Forum
EULAR Recommendations Podcast 2023 with Professor Peter Nash & Dr. Andreas Kerschbaumer
Oct 16, 2023
Join Professor Peter Nash from Griffith University and Dr. Andreas Kerschbaumer from Medical University of Vienna as they discuss the updated EULAR recommendations for managing psoriatic arthritis. Topics include systematic literature reviews, challenges in safety questions, impact on medical practice, comparison of AC algorithm and grapple recommendations, and updates to treatment recommendations.
35:13
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Safety is an important consideration when choosing treatment options for psoriatic arthritis, particularly in the case of jack inhibitors and other biological DMARDs.
- Non-musculoskeletal manifestations, such as skin involvement, UBIDAS, and IBD, play a significant role in guiding treatment decisions for psoriatic arthritis, and specific therapies should be chosen based on these manifestations.
Deep dives
The EULA recommendations for the management of psoriatic arthritis have been updated
The podcast episode discusses the recently updated EULA recommendations for the management of psoriatic arthritis. The recommendations were based on a systematic literature review conducted by Dr. Andreas Koshbauma, which included a large task force involving multiple specialties and stakeholders. The update considered new drug approvals, new indications for existing drugs, and new safety concerns. The recommendations aimed to provide guidance on treatment targets, choice of therapies, and the management of different manifestations of psoriatic arthritis.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
